Tatjana Naranda
President & COO at Maxymune Therapeutics.
- Los Altos, CA
- Form D signer
- Maxymune Therapeutics
Raised on Maxymune Therapeutics filings
$2.7M
of $4.5M offered across 2 Form D filings
- Form D filings
- 2
- Last filing
- Jun 3, 2026
Company
Maxymune Therapeutics
Biotech · Los Altos, CA
Pioneering biopharmaceutical company focused on developing innovative immunotherapies aimed at treating various immune-related diseases
Pioneering biopharmaceutical company focused on developing innovative immunotherapies aimed at treating various immune-related diseases
- Investors
- 8
- Founded
- 2023
- Still open
- $1.8M
Maxymune Therapeutics filings
| Filed | Security | Sold of offered | Filing |
|---|---|---|---|
| Jun 3, 2026 | Option to acquire | $2.7M/ $4.5M | Form D/A |
| Feb 28, 2025 | Option to acquire | $850K/ $2.5M | Form D |
